Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumab
- 18 April 2012
- journal article
- letter
- Published by Springer Nature in Journal of Neurology
- Vol. 259 (9) , 1976-1978
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Complete regression of a previously untreated melanoma brain metastasis with ipilimumabMelanoma Research, 2010
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 AntibodyClinical Cancer Research, 2009
- Prognostic factors and outcomes in patients with leptomeningeal melanomatosisNeuro-Oncology, 2008
- CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNSNature Clinical Practice Oncology, 2008
- [Guideline 'Leptomeningeal metastases of solid tumours'].2007
- Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the TumorThe Journal of Immunology, 2005
- Imaging features of leptomeningeal metastasesClinical Radiology, 1999
- The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasisJournal of Neurology, 1999
- Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasisAnnals of Neurology, 1995